【佳學(xué)基因檢測(cè)】應(yīng)對(duì)資源、應(yīng)對(duì)過程和心理健康

品牌基因檢測(cè)價(jià)格表2022年合理性

學(xué)習(xí)精神病基因組學(xué)個(gè)性化藥物選擇知悉《Annu Rev Clin Psychol》在.?2007;3:377-401.發(fā)表了一篇題目為《應(yīng)對(duì)資源、應(yīng)對(duì)過程和心理健康》腫瘤靶向藥物治療基因檢測(cè)臨床研究文章。該研究由Shelley E Taylor, Annette L Stanton等完成。促進(jìn)了腫瘤的正確治療與個(gè)性化用藥的發(fā)展，進(jìn)一步強(qiáng)調(diào)了基因信息檢測(cè)與分析的重要性。

精神科神經(jīng)科致病基因及正確治療臨床研究?jī)?nèi)容關(guān)鍵詞：

全基因組關(guān)聯(lián)研究,影像遺傳學(xué),神經(jīng)精神疾病,組織清理

神經(jīng)科用藥指導(dǎo)基因檢測(cè)臨床應(yīng)用結(jié)果

應(yīng)對(duì)，被定義為以行動(dòng)為導(dǎo)向的心理努力，以管理壓力事件所產(chǎn)生的需求，因其對(duì)壓力相關(guān)的心理和身體健康結(jié)果的重大影響及其干預(yù)潛力而逐漸得到承認(rèn)。我們回顧了有助于這一過程的應(yīng)對(duì)資源，包括樂觀、掌握、自尊和社會(huì)支持方面的個(gè)體差異，并檢查評(píng)估和應(yīng)對(duì)過程，尤其是那些以接近或回避為標(biāo)志的過程。我們解決了基因、早期生活經(jīng)驗(yàn)和基因-環(huán)境相互作用中應(yīng)對(duì)資源和過程的起源，并解決了可能有助于評(píng)估應(yīng)對(duì)干預(yù)措施的應(yīng)對(duì)的神經(jīng)基礎(chǔ)。最后，我們概述了改善應(yīng)對(duì)過程的可能干預(yù)策略。

神經(jīng)及精神疾病及其并發(fā)征、合并征國(guó)際數(shù)據(jù)庫(kù)描述：

Coping, defined as action-oriented and intrapsychic efforts to manage the demands created by stressful events, is coming to be recognized both for its significant impact on stress-related mental and physical health outcomes and for its intervention potential. We review coping resources that aid in this process, including individual differences in optimism, mastery, self-esteem, and social support, and examine appraisal and coping processes, especially those marked by approach or avoidance. We address the origins of coping resources and processes in genes, early life experience, and gene-environment interactions, and address neural underpinnings of coping that may shed light on evaluating coping interventions. We conclude by outlining possible intervention strategies for improving coping processes.

• 上一篇：【佳學(xué)基因檢測(cè)】阿片類藥物成癮、遺傳易感性和藥物治療：綜述
• 下一篇：【佳學(xué)基因檢測(cè)】藥物基因組學(xué)的正確精神病學(xué)應(yīng)用：人工智能和機(jī)器學(xué)習(xí)方法

• 收藏
• 挑錯(cuò)
• 推薦
• 打印